Medicover AB (LTS:0RPS)
kr 218.5 +1 (+0.46%) Market Cap: 33.21 Bil Enterprise Value: 48.59 Bil PE Ratio: 35.78 PB Ratio: 5.64 GF Score: 89/100

Q2 2026 Medicover AB Earnings Call Transcript

Jul 22, 2026 / 07:30AM GMT
Release Date Price: kr226.5 (+2.95%)

Key Points

Positve
  • Medicover AB (FRA:5M0B) reported double-digit organic revenue growth of 11.8%, marking the sixth consecutive quarter of improved margins.
  • The diagnostic business showed strong performance with an 8.5% increase in revenue and a 10.9% rise in organic growth.
  • India's operations demonstrated significant growth, with revenue increasing by 23.1% in euros and 39.6% in local currency.
  • The company successfully reduced its leverage from 3.6 last year to 2.9, indicating improved financial stability.
  • Fee-for-service revenue streams, a major focus for the company, showed strong growth, contributing to overall revenue stability.
Negative
  • The healthcare services segment faced tough comparables, resulting in a slight margin rate dilution of 30 basis points year-on-year.
  • Membership numbers in Romania declined due to contract management decisions, impacting overall membership growth.
  • India's new hospital openings contributed to EBITDA losses, with a significant portion of the loss attributed to these new facilities.
  • The political and fiscal situation in Romania created instability, affecting governmental revenue streams and requiring operational adjustments.
  • Despite strong growth in India, the margins remain diluted, indicating ongoing challenges in achieving profitability in this region.
Operator

Welcome to the Medicover Q2 2026 report presentation. For the first part of the conference call, the participants will be in listen-only mode. During the questions and answers session, participants are able to ask questions by dialing pound key five on their telephone keypad. Now I will hand the conference over to the speakers, CEO John Stubbington and CFO Anand Patel.

John Stubbington
Medicover AB - Chief Executive Officer

Morning, everybody. It's John here. Welcome to our Q2 2026 report. I think we've got a quarter of a positive progression, which we're very pleased with.

You can see it's another quarter of double-digit organic revenue growth to margin expansion, which is really what we're aiming for. Strong organic growth of 11.8%.

And this is our sixth quarter of improved margins, so we're very pleased with that. It's a record that we're proud of and hope to continue as we go forward.

Just a reminder for everybody, this particular quarter has a very strong comparable base.

Last year, we made significant movements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot